Rekisteröidy luodaksesi hälytyksiä instrumenteille,
taloustapahtumille ja seuraamiesi kirjoittajien sisällölle
Rekisteröidy ilmaiseksi Onko sinulla jo tili? Kirjaudu
Lainaukset
Kaikki instrumenttityypit
- Kaikki instrumenttityypit
- Indeksi
- Pääoma
- ETF:t
- Varat
- Hyödyke
- Valuutat
- Krypto
- Joukkov.
- Sertifikaatit
Yritä tehdä uusi haku
Vapauta ensiluokkaiset tiedot: jopa <50 % alennus InvestingPro HYÖDYNNÄ TARJOUS
Gmo International Equity Fund Class Iii (GMOIX)
Lisää salkkuun / Poista salkusta
Lisää salkkuun
24,44
-0,19
-0,77%
Tyyppi:
Rahasto
Markkinat:
Yhdysvallat
Liikkeeseenlaskija:
GMO
Perusta:
MSCI EAFE Net
Omaisuusluokka:
Osake
- Morningstar-luokitus:
- Varat yhteensä: 370,96M
GMO International Equity III
24,44
-0,19
-0,77%
GMOIX - yleiskatsaus
Tältä sivulta löytyy syväluotaava Gmo International Equity Fund Class Iii-profiili. Saat lisätietoja GMOIX-avainjohtajista, -kokonaisvaroista, -sijoitusstrategiasta ja -yhteystietoista.
Yhteystiedot
Osoite
40 Rowes Wharf
Boston,MA 02110
United States
Boston,MA 02110
United States
Puhelin
+1 617 3307500
Faksi
617-261-0134
Verkko
www.gmo.com
Ylin johto
| Nimi | Otsikko | Vuodesta | Saakka |
|---|---|---|---|
| George Sakoulis | - | 2024 | now |
| Elämäkerta | Dr. Sakoulis is the Head of Investment Teams at GMO and a partner of the firm. He previously worked at GMO from 2009 to 2014 leading quantitative research for GMO’s Emerging Markets Equity team. Prior to rejoining GMO in 2020, he was most recently a Managing Director and Head of Global Multi-Asset Solutions for QMA, where he focused on systematic total and absolute return investment solutions. Before that, he led QMA’s Global Portfolio Solutions group. Previously, Dr. Sakoulis also served as the Director of European Equity Strategies for Numeric Investors and as a Director for UBS O’Connor. He earned his bachelor's degree in Economics and Statistics from San Francisco State University and his MA in Economics and PhD in Financial Econometrics from the University of Washington. | ||
| Warren Chiang | Research Associate | 2024 | now |
| Elämäkerta | Mr. Chiang oversees portfolio management for GMO’s Systematic Equity team and is the head of the Emerging Markets Select Equity team. He is a partner of the firm. Prior to joining GMO in 2015, he worked at Mellon Capital Management as a Managing Director of Active Equity Strategies. Previously, he worked at the Federal Reserve Bank of San Francisco as a research associate. Mr. Chiang earned his bachelor's degree in Economics and his MBA from the University of California Berkeley. He is a CFA charterholder. | ||
| Simon Harris | Head of GMO Systematic Equity | 2019 | now |
| Elämäkerta | Mr. Harris is Head of GMO’s Systematic Equity team and is a partner of the firm. In his decades at GMO, Simon has had extensive portfolio management, quantitative research, and team leadership experience including as the head of the Global Equity team and head of the UK Equity team prior to its merger with Global Equity. Previously, he also served as co-CEO of GMO UK Ltd. Prior to joining GMO in 1989, he earned his BSc in Mathematics from The City University (London). Mr. Harris is a Fellow of The Chartered Institute for Securities & Investment. | ||
| Josh White | Portfolio Manager | 2019 | 2021 |
| Neil Constable | Head | 2015 | 2019 |
| Elämäkerta | Dr. Constable is Head of Global Equity Team. Dr. Constable has been responsible for providing portfolio management and research services to GMO’s global equity portfolios since 2006. | ||
| Chris Fortson | - | 2015 | 2016 |
| Elämäkerta | Head of Quantitative Research, Global Equity, GMO; joined GMO in 2009. | ||
| Sam Wilderman | Co-Head | 2013 | 2016 |
| Elämäkerta | Mr. Wilderman is the co-Head of Asset Allocation Team and Developed Fixed Income Team for GMO. Mr. Wilderman has been responsible for overseeing the portfolio management of GMO’s asset allocation portfolios since September 2012, and for overseeing the portfolio management of GMO’s developed fixed income portfolios since November 2014. Previously, Mr. Wilderman had been Co-Head of GMO’s Global Equity Team since 2009. | ||
| Ben Inker | Director | 2013 | 2016 |
| Elämäkerta | Mr. Inker is co-head of GMO’s Asset Allocation team, a member of the GMO Board of Directors and a partner of the firm. He joined GMO in 1992 following the completion of his bachelor's degree in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder. | ||
| David Cowan | Portfolio Manager | 2012 | 2016 |
| Elämäkerta | Mr. Cowan, Co-Head, Global Equity Team, GMO. Mr. Cowan has provided research and portfolio management services to GMO’s global equity portfolios since 2006 and has been the Co-Head of the Global Equity Team since September 2012. | ||
| Thomas R. Hancock | Portfolio Manager | 1998 | 2015 |
| Elämäkerta | Dr. Hancock is the head of the Focused Equity team, a portfolio manager for GMO’s Quality Strategies and a partner of the firm. Previously at GMO, he was co-head of the Global Equity team. Prior to joining GMO in 1995, he was a research scientist at Siemens and a software engineer at IBM. Dr. Hancock holds BS and MS degrees from Rensselaer Polytechnic Institute and a PhD in Computer Science from Harvard University. | ||
Kirjoita ajatuksiasi kohteesta Gmo International Equity Fund Class Iii
Haluatko varmasti poistaa tämän graafin?
Poista Peruuta
Korvaa liitteenä oleva graafi uudella graafilla?
Korvaa Peruuta
Ohjeita kommentoimiseen
Lisää graafi kommenttiin
Vahvista esto
Haluatko varmasti estää käyttäjän %USER_NAME%?
Toimiessasi näin sinä ja %USER_NAME% ette voi nähdä toistenne Investing.com-julkaisuja.
Käyttäjän %USER_NAME% lisääminen estoluetteloosi onnistui
Koska olet juuri poistanut eston tämän henkilön kohdalla, sinun täytyy odottaa 48 tuntia ennen estämisen uusimista.
Raportoi tämä kommentti
Mielestäni tämä kommentti on:
Kommentti merkitty
Kiitos!
Raporttisi on lähetetty moderaattoreidemme tarkastettavaksi